Abbott’s Continuous Glucose Monitor System Obtains Highest Accuracy in a Clinical Study
- After obtaining FDA approval on May 31, 2022, the next-generation continuous glucose monitor (CGM) system FreeStyle Libre 3 has garnered another major win for its manufacturer, Abbott. Clinical data presented at the American Diabetes Association (ADA’s) annual scientific sessions in New Orleans portrayed the device’s accuracy in...
